Showing results 1 to 20 of 21
next >
| Issue Date | Title | Author(s) |
| 2015 | 4SCAR19 Chimeric Antigen Receptor-Modified T Cells As a Breakthrough Therapy for Highly Chemotherapy-Resistant Late-Stage B Cell Lymphoma Patients with Bulky Tumor Mass | Chang, Lung-Ji; Dong, Lujia; Zhu, Jun; Ying, Zhitao; Kuo, Hao-Hsian; Liu, Yuchen; Song, Yu-Qin; Wang, Xiao-Pei; Jia, Yong-Qian; Niu, Ting; Liu, Ting; Pan, Ling; Liu, Zhuo-Gang; Li, Tong; Li, Ying-Chun; Yao, Kun; Ke, Xiaoyan; Jing, Hongmei; Bao, Fang |
| 2015 | 4SCAR19 Chimeric Antigen Receptor-Modified T Cells As a Breakthrough Therapy for Highly Chemotherapy-Resistant Late-Stage B Cell Lymphoma Patients with Bulky Tumor Mass | Chang, Lung-Ji; Dong, Lujia; Zhu, Jun; Ying, Zhitao; Kuo, Hao-Hsian; Liu, Yuchen; Song, Yu-Qin; Wang, Xiao-Pei; Jia, Yong-Qian; Niu, Ting; Liu, Ting; Pan, Ling; Liu, Zhuo-Gang; Li, Tong; Li, Ying-Chun; Yao, Kun; Ke, Xiaoyan; Jing, Hongmei; Bao, Fang |
| Oct-2021 | Circularly permuted TRAIL (CPT) combined with Thalidomide and Dexamethasone in patients with relapsed/refractory Multiple Myeloma: a randomized, double-blind, placebo-controlled phase 3 study | Chen, Wenming; Xia, Zhongjun; Fang, Baijun; Fu, Chengcheng; Li, Wei; Yang, Linhua; Ke, Xiaoyan; Jiang, Hua; Weng, Jianyu; Liu, Li; Zhao, Yaozhong; Zhang, Xuejun; Liu, Aichun; Huang, Zhongxia; Shi, Qingzhi; Gao, Yuhuan; Chen, Xiequn; Pan, Ling; Cai, Zhen; Wang, Zhao; Wang, Yafei; Zhang, Yizhuo; Fan, Yaqun; Hou, Ming; Yang, Shifang |
| 2017 | Circularly permuted TRAIL plus thalidomide and dexamethasone versus thalidomide and dexamethasone for relapsed/refractory multiple myeloma: a phase 2 study | Leng, Yun; Hou, Jian; Jin, Jie; Zhang, Mei; Ke, Xiaoyan; Jiang, Bin; Pan, Ling; Yang, Linhua; Zhou, Fang; Wang, Jianmin; Wang, Zhao; Liu, Li; Li, Wei; Shen, Zhixiang; Qiu, Lugui; Chang, Naibai; Li, Jianyong; Liu, Jing; Pang, Hongyan; Meng, Haitao; Wei, Peng; Jiang, Hua; Liu, Yan; Zheng, Xiangjun; Yang, Shifang; Chen, Wenming |
| 2013 | Effective Noninvasive Zygosity Determination by Maternal Plasma Target Region Sequencing | Zheng, Jing; Xu, Chenming; Guo, Jing; Wei, Yuan; Ge, Huijuan; Li, Xuchao; Zhang, Chunlei; Jiang, Haojun; Pan, Ling; Tang, Weiping; Xie, Weiwei; Zhang, Hongyun; Zhao, Yangyu; Jiang, Fuman; Chen, Shengpei; Wang, Wei; Xu, Xun; Chen, Fang; Huang, Hefeng; Jiang, Hui |
| May-2024 | External Validation of the Kidney Failure Risk Equation Among Urban Community-Based Chinese Patients With CKD | Pan, Ling; Wang, Jinwei; Deng, Yang; Sun, Yexiang; Nie, Zhenyu; Sun, Xiaoyu; Yang, Chao; Ding, Guohui; Zhao, Ming-Hui; Liao, Yunhua; Zhang, Luxia |
| 2013 | High-density lipoprotein nitration and chlorination catalyzed by myeloperoxidase impair its effect of promoting endothelial repair | Pan, Bing; Yu, Baoqi; Ren, Hui; Willard, Belinda; Pan, Ling; Zu, Lingyun; Shen, Xiaoli; Ma, Yijing; Li, Xiuli; Niu, Chenguang; Kong, Jinge; Kang, Siyu; Chen, Y. Eugene; Pennathur, Subramaniam; Zheng, Lemin |
| 2012 | High-density lipoprotein of patients with type 2 diabetes mellitus elevates the capability of promoting migration and invasion of breast cancer cells | Pan, Bing; Ren, Hui; Ma, Yijing; Liu, Donghui; Yu, Baoqi; Ji, Liang; Pan, Ling; Li, Jing; Yang, Liangui; Lv, Xiaofeng; Shen, Xiaoli; Chen, Bin; Zhang, Youyi; Willard, Belinda; He, Yubin; Zheng, Lemin |
| May-2023 | Imatinib compared with second-generation tyrosine kinase-inhibitors in persons with chronic myeloid leukemia presenting in accelerated phase | Yang, Sen; Zhang, Xiaoshuai; Gale, Robert Peter; Du, Xin; Chen, Chun-yan; Weng, Jian-yu; Huang, Jian; Li, Fei; Zeng, Yun; Xiao, Zhen; Hu, Jian-da; Yang, Li-jie; Liu, Zhuo-gang; Li, Guo-hui; Sun, Xiu-li; Yang, Wei; Feng, Ru; Han, Yan-qiu; Jing, Yu; Xu, Na; Liu, Xiao-li; Liu, Zhen-fang; Wang, Xiao-dong; Wu, Shi-xin; Liang, Rong; Zhang, Yan-li; Yang, Yun-fan; Zhu, Huan-ling; Pan, Ling; Meng, Li; Zhao, Yan-hong; Yi, Hai; Liu, Yi-lan; Zhang, Wei-hua; Zheng, Yuan-jun; Zhou, Ze-ping; Chen, Su-ning; Qiu, Hui-ying; Li, Wei-ming; Jia, Zhi-lin; Bai, Yan-liang; Lin, Li-e; Liu, Bing-cheng; Liu, Chun-shui; Luo, Jian-min; Meng, Jun-xia; Sun, Zhi-qiang; Zhang, Yan-qing; Huang, Xiao-jun; Jiang, Qian |
| 2023 | Indirect comparisons of efficacy of zanubrutinib versus orelabrutinib in patients with relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma or relapsed or refractory mantle cell lymphoma | Song, Yuqin; Zhou, Keshu; Yang, Shenmiao; Hu, Jianda; Zou, Dehui; Gao, Sujun; Pan, Ling; Wang, Tingyu; Yang, Haiyan; Zhang, Huilai; Zhou, Daobin; Ji, Jie; Xu, Wei; Feng, Ru; Jin, Jie; Lv, Fangfang; Huang, Haiwen; Fan, Xiaosi; Xu, Sheng; Zhu, Jun |
| 15-Nov-2022 | Is the 2nd Generation Tyrosine Kinase-Inhibitor a Better Initial Therapy Than Imatinib in Persons with Chronic Myeloid Leukemia Presenting in Accelerated Phase: A Multicenter Retrospective Study | Yang, Sen; Zhang, Xiaoshuai; Zhang, Yanli; Du, Xin; Weng, Jianyu; Zhu, Huanling; Pan, Ling; Yang, Yun-fan; Meng, Li; Liu, Zhenfang; Liu, Xiaoli; Xu, Na; Chen, Chunyan; Wang, Xiaodong; Liang, Rong; Huang, Jian; Li, Guohui; Liu, Chunshui; Lin, Hai; Hu, Jianda; Fei, Li; Liu, Bingcheng; Li, Weiming; Liu, Zhuogang; Yang, Wei; Huang, Xiao Jun; Jiang, Qian |
| 15-Nov-2022 | A Predictive Scoring System for Therapy Failure in Persons with Chronic Myeloid Leukemia Receiving Initial a Second-Generation Tyrosine Kinase Inhibitor Therapy | Zhang, Xiaoshuai; Liu, Bingcheng; Huang, Jian; Zhang, Gongli; Liu, Xiaoli; Xu, Na; Li, Weiming; Du, Xin; Weng, Jianyu; Lin, Hai; Liang, Rong; Chen, Chunyan; Zhu, Huanling; Pan, Ling; Yang, Yun-fan; Wang, Xiaodong; Li, Guohui; Liu, Zhuogang; Liu, Zhenfang; Hu, Jianda; Liu, Chunshui; Fei, Li; Yang, Wei; Meng, Li; Gale, Robert Peter; Huang, Xiao Jun; Jiang, Qian |
| 2-Nov-2023 | A Predictive Scoring System for Therapy Failure of Tyrosine-Kinase Inhibitors in Patients with Chronic-Phase Chronic Myeloid Leukemia | Zhang, Xiao-shuai; Liu, Bingcheng; Huang, Jian; Du, Xin; Zhang, Yanli; Xu, Na; Liu, Xiaoli; Li Weiming; Lin, Hai; Zhu, Huanling; Yang, Yunfan; Pan, Ling; Huang, Xiao-jun; Jiang, Qian |
| 2012 | Prevalence of chronic kidney disease in China: a cross-sectional survey | Zhang, Luxia; Wang, Fang; Wang, Li; Wang, Wenke; Liu, Bicheng; Liu, Jian; Chen, Menghua; He, Qiang; Liao, Yunhua; Yu, Xueqing; Chen, Nan; Zhang, Jian-e; Hu, Zhao; Liu, Fuyou; Hong, Daqing; Ma, Lijie; Liu, Hong; Zhou, Xiaoling; Chen, Jianghua; Pan, Ling; Chen, Wei; Wang, Weiming; Li, Xiaomei; Wang, Haiyan |
| 2016 | The prevalence, awareness, treatment and control of dyslipidemia among adults in China | Pan, Ling; Yang, Zhenhua; Wu, Yue; Yin, Rui-Xing; Liao, Yunhua; Wang, Jinwei; Gao, Bixia; Zhang, Luxia |
| 15-Nov-2022 | Subjects with Chronic Myeloid Leukemia Identified As Intermediate- or High-Risk Subjects Using the Imatinib Therapy Failure (IMTF) Model Benefit from Initial Therapy with a Second-Generation Tyrosine Kinase Inhibitor | Zhang, Xiaoshuai; Liu, Bingcheng; Huang, Jian; Zhang, Gongli; Liu, Xiaoli; Xu, Na; Li, Weiming; Du, Xin; Weng, Jianyu; Lin, Hai; Liang, Rong; Chen, Chunyan; Zhu, Huanling; Pan, Ling; Yang, Yun-fan; Wang, Xiaodong; Li, Guohui; Liu, Zhuogang; Liu, Zhenfang; Hu, Jianda; Liu, Chunshui; Fei, Li; Yang, Wei; Meng, Li; Gale, Robert Peter; Huang, Xiao Jun; Jiang, Qian |
| 2014 | Transiently Elevated AST/LDH Are Associated with Clinical Response to Recombinant Circularly Permuted TRAIL (CPT) Plus Thalidomide in Patients with Relapsed and/or Refractory Multiple Myeloma | Chen, Wenming; Wei, Peng; Yang, Shifang; Zheng, Xiangjun; Qiu, Lugui; Hou, Jian; Zhang, Xuejun; Wang, Zhao; Ke, Xiaoyan; Pan, Ling; Pang, Hongyan |
| 11-May-2020 | Treatment of relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma with the BTK inhibitor zanubrutinib: phase 2, single-arm, multicenter study | Xu, Wei; Yang, Shenmiao; Zhou, Keshu; Pan, Ling; Li, Zengjun; Zhou, Jianfeng; Gao, Sujun; Zhou, Daobin; Hu, Jianda; Feng, Ru; Huang, Haiwen; Ji, Meng; Guo, Haiyi; Huang, Jane; Novotny, William; Feng, Shibao; Li, Jianyong |
| 15-Nov-2022 | Validation and Use of Predictive Scoring Systems for Molecular Responses in 5,203 Persons with Chronic Myeloid Leukemia | Zhang, Xiaoshuai; Liu, Bingcheng; Huang, Jian; Zhang, Gongli; Liu, Xiaoli; Xu, Na; Li, Weiming; Du, Xin; Weng, Jianyu; Lin, Hai; Liang, Rong; Chen, Chunyan; Zhu, Huanling; Pan, Ling; Yang, Yunfan; Wang, Xiaodong; Li, Guohui; Liu, Zhuogang; Liu, Zhenfang; Hu, Jianda; Liu, Chunshui; Fei, Li; Yang, Wei; Meng, Li; Gale, Robert Peter; Huang, Xiao Jun; Jiang, Qian |
| Feb-2023 | Zanubrutinib in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma: final results and correlative analysis of lymphocytosis | Xu, Wei; Yang, Shenmiao; Zhou, Keshu; Pan, Ling; Li, Zengjun; Gao, Sujun; Zhou, Daobin; Hu, Jianda; Feng, Ru; Huang, Haiwen; Wang, Tingyu; Li, Dengju; Ji, Meng; Guo, Haiyi; Zhao, Xia; Wu, Binghao; Yu, Yiling; Wang, Yu; Huang, Jane; Novotny, William; Li, Jianyong |
